Related references
Note: Only part of the references are listed.Expression level of insulin-like growth factor binding protein 5 mRNA is a prognostic factor for breast cancer
Xiaoqing Li et al.
CANCER SCIENCE (2007)
Over-expression of PTEN sensitizes human ovarian cancer cells to cisplatin-induced apoptosis in a p53-dependent manner
Xiaojuan Yan et al.
GYNECOLOGIC ONCOLOGY (2006)
Effects of a combined treatment with mTOR inhibitor RAD001 and tamoxifen in vitro on growth and apoptosis of human cancer cells
Oliver Treeck et al.
GYNECOLOGIC ONCOLOGY (2006)
p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis
Nadia Coltella et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Oncogenic Ras inhibits anoikis of intestinal epithelial cells by preventing the release of a mitochondrial pro-apoptotic protein Omi/HtrA2 into the cytoplasm
Zaiping Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
被撤回的出版物: Potentiation of paclitaxel activity by the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin in human ovarian carcinoma cell lines with high levels of activated AKT (Retracted article. See vol. 17, pg. 2075, 2018)
Nivedita Sain et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The neurotrophic receptor TrkB: a drug target in anti-cancer therapy?
CJ Desmet et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
M Cully et al.
NATURE REVIEWS CANCER (2006)
Bcl-XL is functionally non-equivalent for the regulation of growth and survival in human ovarian cancer cells
P Dodier et al.
GYNECOLOGIC ONCOLOGY (2006)
Metastasis: a question of life or death
P Mehlen et al.
NATURE REVIEWS CANCER (2006)
Neurotrophin system expression in human pulmonary carcinoid tumors
A Ricci et al.
GROWTH FACTORS (2005)
Inhibition of phosphatidylinositol 3-kinase sensitizes ovarian cancer cells to carboplatin and allows adjunct chemotherapy treatment
SD Westfall et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Biological effects of TrkA and TrkB receptor signaling in neuroblastoma
A Schramm et al.
CANCER LETTERS (2005)
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA mRNA amplification contributes to cisplatin resistance in an ovarian cancer cell line
S Lee et al.
GYNECOLOGIC ONCOLOGY (2005)
Genetic and pharmacologic identification of Akt as a mediator of brain-derived neurotrophic factor/TrκB rescue of neuroblastoma cells from chemotherapy-induced cell death
ZJ Li et al.
CANCER RESEARCH (2005)
Microarray analysis reveals differential gene expression patterns and regulation of single target genes contributing to the opposing phenotype of TrkA- and TrkB-expressing neuroblastomas
JH Schulte et al.
ONCOGENE (2005)
Role of K-ras and Pten in the development of mouse models of endometriosis and endometrioid ovarian cancer
DM Dinulescu et al.
NATURE MEDICINE (2005)
TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary
A Paredes et al.
DEVELOPMENTAL BIOLOGY (2004)
Human intestinal epithelial crypt cell survival and death:: Complex modulations of Bcl-2 homologs by Fak, PI3-K/Akt-1. MEK/Erk, and p38 signaling pathways
C Harnois et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Suppression of anoikis and induction of metastasis by the neurotrophic receptor TrkB
S Douma et al.
NATURE (2004)
G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells
N Gao et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2004)
Inhibition of inhibitor of nuclear factor-κB phosphorylation increase the efficacy of paclitaxel in in vitro and in vivo ovarian cancer models
S Mabuchi et al.
CLINICAL CANCER RESEARCH (2004)
The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers
KW Cheng et al.
NATURE MEDICINE (2004)
Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts
S Uttamsingh et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Mutational analysis of the tyrosine kinome in colorectal cancers
A Bardelli et al.
SCIENCE (2003)
The role of neurotrophin receptors in female germ-cell survival in mouse and human
N Spears et al.
DEVELOPMENT (2003)
Regulation of TRKB surface expression by brain-derived neurotrophic factor and truncated TRIM Isoforms
A Haapasalo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A novel form of constitutively active farnesylated Akt I prevents mammary epithelial cells from anoikis and suppresses chemotherapy-induced apoptosis
M Schmidt et al.
BRITISH JOURNAL OF CANCER (2002)
The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria
F Tsuruta et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A DNA vector-based RNAi technology to suppress gene expression in mammalian cells
GC Sui et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Autocrine expression of neurotrophins and their receptors in prostate cancer
F Satoh et al.
INTERNATIONAL JOURNAL OF UROLOGY (2001)
Akt regulates cell survival and apoptosis at a postmitochondrial level
HL Zhou et al.
JOURNAL OF CELL BIOLOGY (2000)
Matrix detachment induces caspase-dependent cytochrome c release from mitochondria:: inhibition by PKB/Akt but not Raf signalling
M Rytömaa et al.
ONCOGENE (2000)
Share Paper
